Health Condition 1: N186- End stage renal disease
Conditions
Interventions
Intervention1: Plasmalyte fluid: Giving intravenous route, bolus of 250ml and maintenance dose of 4ml/kg/hr fluid given throughout the surgery and calculating Strong ion difference at end of surgery
Sponsors
PGIMER
Eligibility
Inclusion criteria
Inclusion criteria: All patients with ESRD Scheduled for renal transplant surgery
Exclusion criteria
Exclusion criteria: Active coronary disease Congestive heart failure Atrial fibrillation or flutter Valvular heart disease Significant pulmonary insufficiency Cadaveric renal transplant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine inter group difference in strong ion difference at end of surgeryTimepoint: At end of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood urea nitrogen and serum creatinineTimepoint: On day one post operative;Graft failureTimepoint: Within seven days;Serum potassium chloride sodium lactateTimepoint: On day one post operative;Total fluid administered at end of surgeryTimepoint: At end of surgery;Urine outputTimepoint: 24hrs | — |
Countries
India
Contacts
Public ContactSachin kumar
Postgraduate institute of medical education and research Chandigarh
Outcome results
None listed